{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:05:23Z","timestamp":1779469523449,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030774","name":"Brazilian Society of Rheumatology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01709-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:13:50Z","timestamp":1779466430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of osteoporosis in older men: a systematic review of randomized trials of pharmacological and non-pharmacological strategies"],"prefix":"10.1007","volume":"21","author":[{"given":"Marco Antonio Ara\u00fajo","family":"da Rocha-Loures","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano Augusto","family":"de Freitas Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Christina","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Brandao","family":"de Resende Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Silva","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane Aline","family":"Paupitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mailze Campos","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Lucia","family":"Szejnfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Roberta Melo","family":"Pereira Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Merchan Ferraz","family":"Grizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Rocha Bernardes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Manjurma","family":"da Silva Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Silveira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Waclawovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1709_CR1","doi-asserted-by":"publisher","unstructured":"Kanis  JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int 4(6):368\u201381. https:\/\/doi.org\/10.1007\/BF01622200","DOI":"10.1007\/BF01622200"},{"issue":"11","key":"1709_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrendo.2013.171","volume":"9","author":"JS Walsh","year":"2013","unstructured":"Walsh JS, Eastell R (2013) Osteoporosis in men. Nat Rev Endocrinol 9(11):637\u2013645","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"1709_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726\u20131733","journal-title":"Osteoporos Int"},{"key":"1709_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/boneres.2014.1","author":"RA Adler","year":"2014","unstructured":"Adler RA (2014) Osteoporosis in men: a review. Bone Res. https:\/\/doi.org\/10.1038\/boneres.2014.1","journal-title":"Bone Res"},{"key":"1709_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2888","author":"S Khosla","year":"2016","unstructured":"Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.2888","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1709_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0149-2918(04)90002-1","volume":"26","author":"WP Olszynski","year":"2004","unstructured":"Olszynski WP, Davison SK, Adachi JD, Brown JP, Cummings SR, Hanley DA et al (2004) Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 26(1):15\u201328","journal-title":"Clin Ther"},{"key":"1709_CR7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1740","author":"S Khosla","year":"2010","unstructured":"Khosla S (2010) Update in male osteoporosis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2009-1740","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1709_CR8","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","volume":"86","author":"JD Ringe","year":"2001","unstructured":"Ringe JD, Faber H, Dorst A (2001) Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 86(11):5252\u20135255","journal-title":"J Clin Endocrinol Metab"},{"key":"1709_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arrct.2023.100313","author":"K Hu","year":"2024","unstructured":"Hu K, Cassimatis M, Girgis C (2024) Exercise and musculoskeletal health in men with low bone mineral density: a systematic review. Arch Rehabil Res Clin Transl. https:\/\/doi.org\/10.1016\/j.arrct.2023.100313","journal-title":"Arch Rehabil Res Clin Transl"},{"key":"1709_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro0816","author":"SA Brown","year":"2007","unstructured":"Brown SA, Guise TA (2007) Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men. Nat Clin Pract Urol. https:\/\/doi.org\/10.1038\/ncpuro0816","journal-title":"Nat Clin Pract Urol"},{"issue":"10","key":"1709_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1-34","journal-title":"J Clin Epidemiol"},{"key":"1709_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (2024) Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024), Version 6.5 edn. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds). London, Cochrane. 20 October 2025"},{"key":"1709_CR13","unstructured":"Schwarzer G, Carpenter JR, Ruecker G (2015) 1 ed  New York: Springer  Publisher"},{"key":"1709_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.150","author":"KA Robinson","year":"2002","unstructured":"Robinson KA, Dickersin K. (2022)  Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed Int J Epidemiol 31(1):150\u20133. https:\/\/doi.org\/10.1093\/ije\/31.1.150","journal-title":"Int J Epidemiol"},{"key":"1709_CR15","doi-asserted-by":"crossref","unstructured":"Glanville J, Foxlee R, Wisniewski S, Noel-Storr A, Edwards M, Dooley G (2019) Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study - PubMed. Health Inform Libr J 36(3)","DOI":"10.1111\/hir.12269"},{"key":"1709_CR16","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al\u00a0(2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"1709_CR17","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"2013","unstructured":"Cohen J (2013) Statistical power analysis for the behavioral sciences (2nd ed.). Routledge. https:\/\/doi.org\/10.4324\/9780203771587"},{"key":"1709_CR18","unstructured":"Higgins JPT, Li T, Deeks JJ (2024) Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins J, Thomas, Chandler J, Cumpston M, Li T, Page M et al (eds) Cochrane handbook for systematic reviews of interventions, Version 6.5 ed. Cochrane"},{"key":"1709_CR19","unstructured":"Balk   M,  Earley  A,  Patel   A, Trikalinos  TA,  Dahabreh   IJ\u00a0(2012) Empirical assessment of within-arm correlation imputation in trials of continuous outcomes [Internet]. Healthcare research and quality (US); Report No.: 12(13)- EHC141-EF"},{"issue":"2","key":"1709_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/sim.8781","volume":"40","author":"L Lin","year":"2021","unstructured":"Lin  L, Aloe    AM\u00a0(2021) Evaluation of various estimators for standardized mean difference in meta-analysis. Stat Med 40(2):403\u2013426. https:\/\/doi.org\/10.1002\/sim.8781","journal-title":"Stat Med"},{"issue":"2","key":"1709_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2307\/2531021","volume":"39","author":"DA Schoenfeld","year":"1983","unstructured":"Schoenfeld DA (1983) Sample-size formula for the proportional-hazards regression model. Biometrics 39(2):499\u2013503","journal-title":"Biometrics"},{"issue":"10","key":"1709_CR22","doi-asserted-by":"publisher","first-page":"e4222","DOI":"10.1210\/clinem\/dgac486","volume":"107","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Sone T, Soen S, Tanaka S, Yamashita A, Inoue T (2022) Abaloparatide increases lumbar spine and hip BMD in Japanese patients with osteoporosis: the Phase 3 ACTIVE-J Study. J Clin Endocrinol Metab 107(10):e4222\u2013e4231","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1709_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00223-002-1085-7","volume":"73","author":"S Gonnelli","year":"2003","unstructured":"Gonnelli S, Cepollaro C, Montagnani A, Bruni D, Caffarelli C, Breschi M et al (2003) Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 73(2):133\u2013139","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1709_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1359\/jbmr.081214","volume":"24","author":"S Boonen","year":"2009","unstructured":"Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD (2009) Once\u2010weekly risedronate in men with osteoporosis: results of a 2\u2010year, placebo\u2010controlled, double\u2010blind, multicenter study. J Bone Miner Res 24(4):719\u2013725","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1709_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00223-008-9207-5","volume":"84","author":"M Kruk","year":"2009","unstructured":"Kruk M, Ralston SH, Albagha OME (2009) LRP5 polymorphisms and response to risedronate treatment in osteoporotic men. Calcif Tissue Int 84(3):171\u2013179","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"1709_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2169\/internalmedicine.47.0591","volume":"47","author":"T Majima","year":"2008","unstructured":"Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K et al (2008) Efficacy of risedronate in Japanese male patients with primary osteoporosis. Intern Med 47(8):717\u2013723","journal-title":"Intern Med"},{"issue":"3","key":"1709_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00296-008-0689-2","volume":"29","author":"JD Ringe","year":"2009","unstructured":"Ringe JD, Farahmand P, Faber H, Dorst A (2009) Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int 29(3):311\u2013315","journal-title":"Rheumatol Int"},{"issue":"10","key":"1709_CR28","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.4314\/tjpr.v20i10.26","volume":"20","author":"Y Qi","year":"2021","unstructured":"Qi Y, Wang W, Sun W, Pan Q (2021) Comparative efficacy and safety of alendronate and teriparatide in bone loss reduction and prevention of vertebral fracture in osteoporotic Chinese patients. Trop J Pharm Res 20(10):2199\u20132204","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"1709_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12020-012-9819-4","volume":"44","author":"MD Walker","year":"2013","unstructured":"Walker MD, Cusano NE, Sliney J Jr, Romano M, Zhang C, McMahon DJ et al (2013) Combination therapy with risedronate and teriparatide in male osteoporosis. Endocrine 44(1):237\u2013246","journal-title":"Endocrine"},{"issue":"1","key":"1709_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-019-0663-5","volume":"15","author":"SY Park","year":"2020","unstructured":"Park SY, Kang M-I, Park HM, Rhee Y, Moon SH, Yoon HK et al (2020) Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis. Arch Osteoporos 15(1):3","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1709_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","volume":"18","author":"ES Orwoll","year":"2003","unstructured":"Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A et al (2003) The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18(1):9\u201317","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1709_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3923\/ijp.2015.148.151","volume":"11","author":"W Lei","year":"2015","unstructured":"Lei W, Chuan W (2015) Efficacy of L-carnitine in the treatment of osteoporosis in men. Int J Pharmacol 11(2):148\u2013151","journal-title":"Int J Pharmacol"},{"issue":"3","key":"1709_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3892\/etm.2017.4078","volume":"13","author":"L Han","year":"2017","unstructured":"Han L, Li S-G, Zhai H-W, Guo P-F, Chen W (2017) Effects of weight training time on bone mineral density of patients with secondary osteoporosis after hemiplegia. Exp Ther Med 13(3):961\u2013965","journal-title":"Exp Ther Med"},{"issue":"5","key":"1709_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.20945\/2359-3997000000563","volume":"66","author":"L Bandeira","year":"2022","unstructured":"Bandeira L, Silva BC, Bilezikian JP (2022) Male osteoporosis. Arch Endocrinol Metab 66(5):739\u2013747","journal-title":"Arch Endocrinol Metab"},{"issue":"9","key":"1709_CR35","first-page":"2792","volume":"82","author":"S Khosla","year":"1997","unstructured":"Khosla S (1997) Idiopathic osteoporosis--is the osteoblast to blame? J Clin Endocrinol Metab 82(9):2792\u20132794","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1709_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40744-016-0030-6","volume":"3","author":"J Zhou","year":"2016","unstructured":"Zhou J, Wang T, Zhao X, Miller DR, Zhai S (2016) Comparative efficacy of bisphosphonates to prevent fracture in men with osteoporosis: a systematic review with network meta-analyses. Rheumatol Ther 3(1):117\u2013128","journal-title":"Rheumatol Ther"},{"issue":"6","key":"1709_CR37","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802\u20131822","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01709-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:13:53Z","timestamp":1779466433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01709-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01709-6","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}],"article-number":"82"}}